Major Pharmaceuticals Methylergonovine Maleate 0.2 mg tablets recalled for subpotency
MAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.
From the FDA notice · Read the official notice ↗ · All The Harvard Drug recalls
What to do
- If you have a prescription for this medication, contact your pharmacy or doctor immediately.
- Do not stop taking your medication without speaking to your doctor.
- Check the lot number on your bottle against the recall list: N02327 (expires 09/2026), N02740 (expires 12/2026), or N03069 (expires 08/2027).
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 790 Cartons.
- Illnesses reported
- None reported
- Manufactured in
- 7000 Cardinal Pl, N/A, Dublin, OH, United States
- Classification
- Class II
- Recall number
- D-0609-2026
In the FDA's words
- Description
- Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10. Subpotent Drug Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027. Distribution: U.S. Nationwide. Affected quantity: 790 Cartons.
- Hazard
- Subpotent Drug